Reductions of carboxylic acid derivatives by silanes in the presence of rhodium complexes were studied. Carboxylic esters were reduced to alcohols by diphenylsilane catalyzed by [RhCl(cod)]2/4PPh3 ...
DIALKYLAMINOALKANOL FRICTION MODIFIERS FOR FUELS AND LUBRICANTS
申请人:Afton Chemical Corporation
公开号:EP3178909A1
公开(公告)日:2017-06-14
A fuel composition, a lubricant composition, and methods for reducing friction or wear of moving parts. The fuel composition includes gasoline and from about 10 to about 500 ppm by weight of a dialkylaminoalkanol of the formula R1(R2)NCH2CH(R3)R4. The lubricant composition includes base oil of lubricating viscosity and from about 0.05 to about 5.0 weight percent of a dialkylaminoalkanol of the formula R1(R2)NCH2CH(R3)R4. In the above formulas wherein R1 is an alkyl group or a hydroxyalkyl group containing from 8 to 50 carbon atoms; R2 is an alkyl group containing from 1 to 4 carbon atoms; R3 is selected from H and OH; and R4 is selected from H, an alkyl group containing from 1 to 4 carbon atoms, and CH2OH and wherein at least one of R3 and R4 contains a hydroxyl group and provided that when R1 is a hydroxyalkyl group, R3 is OH and R4 is CH2OH.
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Dialkylaminoalkanol friction modifiers for fuels and lubricants
申请人:Afton Chemical Corporation
公开号:US10407636B2
公开(公告)日:2019-09-10
A fuel composition, a lubricant composition, and methods for reducing friction or wear of moving parts. The fuel composition includes gasoline and from about 10 to about 500 ppm by weight of a dialkylaminoalkanol of the formula R1(R2)NCH2CH(R3)R4. The lubricant composition includes base oil of lubricating viscosity and from about 0.05 to about 5.0 weight percent of a dialkylaminoalkanol of the formula R1(R2)NCH2CH(R3)R4. In the above formulas wherein R1 is an alkyl group or a hydroxy alkyl group containing from 8 to 50 carbon atoms; R2 is an alkyl group containing from 1 to 4 carbon atoms; R3 is selected from H and OH; and R4 is selected from H, an alkyl group containing from 1 to 4 carbon atoms, and CH2OH and wherein at least one of R3 and R4 contains a hydroxyl group and provided that when R1 is a hydroxyalkyl group, R3 is OH and R4 is CH2OH.
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
申请人:Revolution Medicines, Inc.
公开号:US10980889B1
公开(公告)日:2021-04-20
The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.